Allianz Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.03M Buy
12,483
+7,280
+140% +$1.93M ﹤0.01% 1327
2026
Q1
$570K Sell
5,203
-7,524
-59% -$1.07M ﹤0.01% 1826
2025
Q4
$2.12M Sell
12,727
-33,190
-72% -$5.55M ﹤0.01% 1523
2025
Q3
$8.99M Buy
+45,917
New +$7.55M 0.01% 884

Other funds holding ALAB

Allianz Asset Management's ALAB Position: Q2 2026 in Review

Allianz Asset Management increased its Astera Labs (ALAB) stake by 140% in Q2 2026, buying an estimated $1.93M and bringing the position to 12,483 shares worth $6.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1327.

Allianz Asset Management first reported a position in ALAB in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.99M in Q3 2025. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Allianz Asset Management held 12,483 shares of Astera Labs worth $6.03M as of Q2 2026.
  • Allianz Asset Management bought 7,280 Astera Labs shares in Q2 2026, an estimated $1.93M.
  • Astera Labs made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1327 holding.
  • Allianz Asset Management first reported a position in Astera Labs in Q3 2025 and has held it in 4 quarters since.
  • Allianz Asset Management's Astera Labs position peaked at $8.99M in Q3 2025.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.